Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
40
BNR Quote, Financials, Valuation and Earnings
Last price:
$30.19
Seasonality move
:
-26.53%
Day range:
$28.28 - $31.01
52-week range:
$2.18 - $41.72
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.12x
P/B ratio:
4.80x
Volume:
7.3K
Avg. volume:
26.3K
1-year change:
378.15%
Market cap:
$310.9M
Revenue:
$71.7M
EPS (TTM):
-$1.61
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BNR
Burning Rock Biotech Ltd.
|
-- | -- | -- | -- | -- |
|
CASI
CASI Pharmaceuticals, Inc.
|
-- | -- | -100% | -- | $4.00 |
|
SVA
Sinovac Biotech Ltd.
|
-- | -- | -- | -- | -- |
|
VBIZF
Viva Biotech Holdings
|
-- | -- | -- | -- | -- |
|
WXXWY
WuXi Biologics (Cayman), Inc.
|
-- | -- | -- | -- | -- |
|
ZLAB
Zai Lab Ltd.
|
$123.9M | -$0.42 | 17.43% | -30.7% | $43.88 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BNR
Burning Rock Biotech Ltd.
|
$28.88 | -- | $310.9M | -- | $0.00 | 0% | 4.12x |
|
CASI
CASI Pharmaceuticals, Inc.
|
$0.77 | $4.00 | $15.8M | -- | $0.00 | 0% | 0.45x |
|
SVA
Sinovac Biotech Ltd.
|
$6.47 | -- | $464.9M | -- | $55.00 | 0% | 1.50x |
|
VBIZF
Viva Biotech Holdings
|
$0.3434 | -- | $724.5M | 19.39x | $0.00 | 0% | 3.15x |
|
WXXWY
WuXi Biologics (Cayman), Inc.
|
$10.53 | -- | $21.4B | 29.93x | $0.00 | 0% | 7.94x |
|
ZLAB
Zai Lab Ltd.
|
$19.03 | $43.88 | $2.1B | -- | $0.00 | 0% | 4.62x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BNR
Burning Rock Biotech Ltd.
|
5.69% | 4.079 | 5% | 2.82x |
|
CASI
CASI Pharmaceuticals, Inc.
|
-274.41% | -0.389 | 55.28% | 0.19x |
|
SVA
Sinovac Biotech Ltd.
|
3.46% | 7.263 | 12.91% | 11.22x |
|
VBIZF
Viva Biotech Holdings
|
24.82% | -7.949 | -- | 1.26x |
|
WXXWY
WuXi Biologics (Cayman), Inc.
|
5.93% | -0.126 | -- | 1.98x |
|
ZLAB
Zai Lab Ltd.
|
22.4% | -0.192 | 5.85% | 2.56x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BNR
Burning Rock Biotech Ltd.
|
$13.8M | -$2.3M | -18.96% | -20.71% | -12.26% | $2.2M |
|
CASI
CASI Pharmaceuticals, Inc.
|
$706K | -$10.2M | -405.32% | -70405.41% | -333.14% | -- |
|
SVA
Sinovac Biotech Ltd.
|
-- | -- | -1.02% | -1.05% | -- | -- |
|
VBIZF
Viva Biotech Holdings
|
-- | -- | -1.17% | -1.8% | -- | -- |
|
WXXWY
WuXi Biologics (Cayman), Inc.
|
-- | -- | 7.16% | 7.53% | -- | -- |
|
ZLAB
Zai Lab Ltd.
|
$69.3M | -$48.9M | -21.74% | -26.7% | -42.05% | -$44.5M |
Burning Rock Biotech Ltd. vs. Competitors
-
Which has Higher Returns BNR or CASI?
CASI Pharmaceuticals, Inc. has a net margin of -12.73% compared to Burning Rock Biotech Ltd.'s net margin of -353.92%. Burning Rock Biotech Ltd.'s return on equity of -20.71% beat CASI Pharmaceuticals, Inc.'s return on equity of -70405.41%.
Company Gross Margin Earnings Per Share Invested Capital BNRBurning Rock Biotech Ltd.75.1% -$0.22 $81.9M CASICASI Pharmaceuticals, Inc.22.96% -$0.68 -$6.9M -
What do Analysts Say About BNR or CASI?
Burning Rock Biotech Ltd. has a consensus price target of --, signalling upside risk potential of 35.45%. On the other hand CASI Pharmaceuticals, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 419.48%. Given that CASI Pharmaceuticals, Inc. has higher upside potential than Burning Rock Biotech Ltd., analysts believe CASI Pharmaceuticals, Inc. is more attractive than Burning Rock Biotech Ltd..
Company Buy Ratings Hold Ratings Sell Ratings BNRBurning Rock Biotech Ltd.0 0 0 CASICASI Pharmaceuticals, Inc.1 0 0 -
Is BNR or CASI More Risky?
Burning Rock Biotech Ltd. has a beta of 1.335, which suggesting that the stock is 33.502% more volatile than S&P 500. In comparison CASI Pharmaceuticals, Inc. has a beta of 0.866, suggesting its less volatile than the S&P 500 by 13.412%.
-
Which is a Better Dividend Stock BNR or CASI?
Burning Rock Biotech Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CASI Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Burning Rock Biotech Ltd. pays -- of its earnings as a dividend. CASI Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BNR or CASI?
Burning Rock Biotech Ltd. quarterly revenues are $18.4M, which are larger than CASI Pharmaceuticals, Inc. quarterly revenues of $3.1M. Burning Rock Biotech Ltd.'s net income of -$2.3M is higher than CASI Pharmaceuticals, Inc.'s net income of -$10.9M. Notably, Burning Rock Biotech Ltd.'s price-to-earnings ratio is -- while CASI Pharmaceuticals, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Burning Rock Biotech Ltd. is 4.12x versus 0.45x for CASI Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BNRBurning Rock Biotech Ltd.4.12x -- $18.4M -$2.3M CASICASI Pharmaceuticals, Inc.0.45x -- $3.1M -$10.9M
-
Which has Higher Returns BNR or SVA?
Sinovac Biotech Ltd. has a net margin of -12.73% compared to Burning Rock Biotech Ltd.'s net margin of --. Burning Rock Biotech Ltd.'s return on equity of -20.71% beat Sinovac Biotech Ltd.'s return on equity of -1.05%.
Company Gross Margin Earnings Per Share Invested Capital BNRBurning Rock Biotech Ltd.75.1% -$0.22 $81.9M SVASinovac Biotech Ltd.-- -- $11.8B -
What do Analysts Say About BNR or SVA?
Burning Rock Biotech Ltd. has a consensus price target of --, signalling upside risk potential of 35.45%. On the other hand Sinovac Biotech Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Burning Rock Biotech Ltd. has higher upside potential than Sinovac Biotech Ltd., analysts believe Burning Rock Biotech Ltd. is more attractive than Sinovac Biotech Ltd..
Company Buy Ratings Hold Ratings Sell Ratings BNRBurning Rock Biotech Ltd.0 0 0 SVASinovac Biotech Ltd.0 0 0 -
Is BNR or SVA More Risky?
Burning Rock Biotech Ltd. has a beta of 1.335, which suggesting that the stock is 33.502% more volatile than S&P 500. In comparison Sinovac Biotech Ltd. has a beta of 0.746, suggesting its less volatile than the S&P 500 by 25.394%.
-
Which is a Better Dividend Stock BNR or SVA?
Burning Rock Biotech Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sinovac Biotech Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $55.00 per share. Burning Rock Biotech Ltd. pays -- of its earnings as a dividend. Sinovac Biotech Ltd. pays out -328.35% of its earnings as a dividend.
-
Which has Better Financial Ratios BNR or SVA?
Burning Rock Biotech Ltd. quarterly revenues are $18.4M, which are larger than Sinovac Biotech Ltd. quarterly revenues of --. Burning Rock Biotech Ltd.'s net income of -$2.3M is higher than Sinovac Biotech Ltd.'s net income of --. Notably, Burning Rock Biotech Ltd.'s price-to-earnings ratio is -- while Sinovac Biotech Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Burning Rock Biotech Ltd. is 4.12x versus 1.50x for Sinovac Biotech Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BNRBurning Rock Biotech Ltd.4.12x -- $18.4M -$2.3M SVASinovac Biotech Ltd.1.50x -- -- --
-
Which has Higher Returns BNR or VBIZF?
Viva Biotech Holdings has a net margin of -12.73% compared to Burning Rock Biotech Ltd.'s net margin of --. Burning Rock Biotech Ltd.'s return on equity of -20.71% beat Viva Biotech Holdings's return on equity of -1.8%.
Company Gross Margin Earnings Per Share Invested Capital BNRBurning Rock Biotech Ltd.75.1% -$0.22 $81.9M VBIZFViva Biotech Holdings-- -- $694.7M -
What do Analysts Say About BNR or VBIZF?
Burning Rock Biotech Ltd. has a consensus price target of --, signalling upside risk potential of 35.45%. On the other hand Viva Biotech Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Burning Rock Biotech Ltd. has higher upside potential than Viva Biotech Holdings, analysts believe Burning Rock Biotech Ltd. is more attractive than Viva Biotech Holdings.
Company Buy Ratings Hold Ratings Sell Ratings BNRBurning Rock Biotech Ltd.0 0 0 VBIZFViva Biotech Holdings0 0 0 -
Is BNR or VBIZF More Risky?
Burning Rock Biotech Ltd. has a beta of 1.335, which suggesting that the stock is 33.502% more volatile than S&P 500. In comparison Viva Biotech Holdings has a beta of 0.502, suggesting its less volatile than the S&P 500 by 49.774%.
-
Which is a Better Dividend Stock BNR or VBIZF?
Burning Rock Biotech Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Viva Biotech Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Burning Rock Biotech Ltd. pays -- of its earnings as a dividend. Viva Biotech Holdings pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BNR or VBIZF?
Burning Rock Biotech Ltd. quarterly revenues are $18.4M, which are larger than Viva Biotech Holdings quarterly revenues of --. Burning Rock Biotech Ltd.'s net income of -$2.3M is higher than Viva Biotech Holdings's net income of --. Notably, Burning Rock Biotech Ltd.'s price-to-earnings ratio is -- while Viva Biotech Holdings's PE ratio is 19.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Burning Rock Biotech Ltd. is 4.12x versus 3.15x for Viva Biotech Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BNRBurning Rock Biotech Ltd.4.12x -- $18.4M -$2.3M VBIZFViva Biotech Holdings3.15x 19.39x -- --
-
Which has Higher Returns BNR or WXXWY?
WuXi Biologics (Cayman), Inc. has a net margin of -12.73% compared to Burning Rock Biotech Ltd.'s net margin of --. Burning Rock Biotech Ltd.'s return on equity of -20.71% beat WuXi Biologics (Cayman), Inc.'s return on equity of 7.53%.
Company Gross Margin Earnings Per Share Invested Capital BNRBurning Rock Biotech Ltd.75.1% -$0.22 $81.9M WXXWYWuXi Biologics (Cayman), Inc.-- -- $6.6B -
What do Analysts Say About BNR or WXXWY?
Burning Rock Biotech Ltd. has a consensus price target of --, signalling upside risk potential of 35.45%. On the other hand WuXi Biologics (Cayman), Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Burning Rock Biotech Ltd. has higher upside potential than WuXi Biologics (Cayman), Inc., analysts believe Burning Rock Biotech Ltd. is more attractive than WuXi Biologics (Cayman), Inc..
Company Buy Ratings Hold Ratings Sell Ratings BNRBurning Rock Biotech Ltd.0 0 0 WXXWYWuXi Biologics (Cayman), Inc.0 0 0 -
Is BNR or WXXWY More Risky?
Burning Rock Biotech Ltd. has a beta of 1.335, which suggesting that the stock is 33.502% more volatile than S&P 500. In comparison WuXi Biologics (Cayman), Inc. has a beta of -0.062, suggesting its less volatile than the S&P 500 by 106.225%.
-
Which is a Better Dividend Stock BNR or WXXWY?
Burning Rock Biotech Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. WuXi Biologics (Cayman), Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Burning Rock Biotech Ltd. pays -- of its earnings as a dividend. WuXi Biologics (Cayman), Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BNR or WXXWY?
Burning Rock Biotech Ltd. quarterly revenues are $18.4M, which are larger than WuXi Biologics (Cayman), Inc. quarterly revenues of --. Burning Rock Biotech Ltd.'s net income of -$2.3M is higher than WuXi Biologics (Cayman), Inc.'s net income of --. Notably, Burning Rock Biotech Ltd.'s price-to-earnings ratio is -- while WuXi Biologics (Cayman), Inc.'s PE ratio is 29.93x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Burning Rock Biotech Ltd. is 4.12x versus 7.94x for WuXi Biologics (Cayman), Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BNRBurning Rock Biotech Ltd.4.12x -- $18.4M -$2.3M WXXWYWuXi Biologics (Cayman), Inc.7.94x 29.93x -- --
-
Which has Higher Returns BNR or ZLAB?
Zai Lab Ltd. has a net margin of -12.73% compared to Burning Rock Biotech Ltd.'s net margin of -30.98%. Burning Rock Biotech Ltd.'s return on equity of -20.71% beat Zai Lab Ltd.'s return on equity of -26.7%.
Company Gross Margin Earnings Per Share Invested Capital BNRBurning Rock Biotech Ltd.75.1% -$0.22 $81.9M ZLABZai Lab Ltd.59.62% -$0.33 $979.3M -
What do Analysts Say About BNR or ZLAB?
Burning Rock Biotech Ltd. has a consensus price target of --, signalling upside risk potential of 35.45%. On the other hand Zai Lab Ltd. has an analysts' consensus of $43.88 which suggests that it could grow by 130.56%. Given that Zai Lab Ltd. has higher upside potential than Burning Rock Biotech Ltd., analysts believe Zai Lab Ltd. is more attractive than Burning Rock Biotech Ltd..
Company Buy Ratings Hold Ratings Sell Ratings BNRBurning Rock Biotech Ltd.0 0 0 ZLABZai Lab Ltd.8 1 0 -
Is BNR or ZLAB More Risky?
Burning Rock Biotech Ltd. has a beta of 1.335, which suggesting that the stock is 33.502% more volatile than S&P 500. In comparison Zai Lab Ltd. has a beta of 0.879, suggesting its less volatile than the S&P 500 by 12.141%.
-
Which is a Better Dividend Stock BNR or ZLAB?
Burning Rock Biotech Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Zai Lab Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Burning Rock Biotech Ltd. pays -- of its earnings as a dividend. Zai Lab Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BNR or ZLAB?
Burning Rock Biotech Ltd. quarterly revenues are $18.4M, which are smaller than Zai Lab Ltd. quarterly revenues of $116.2M. Burning Rock Biotech Ltd.'s net income of -$2.3M is higher than Zai Lab Ltd.'s net income of -$36M. Notably, Burning Rock Biotech Ltd.'s price-to-earnings ratio is -- while Zai Lab Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Burning Rock Biotech Ltd. is 4.12x versus 4.62x for Zai Lab Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BNRBurning Rock Biotech Ltd.4.12x -- $18.4M -$2.3M ZLABZai Lab Ltd.4.62x -- $116.2M -$36M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 11.64% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Buy
77
VRT alert for Feb 12
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.
